“OCU200 has the potential to change the treatment landscape for DME, diabetic retinopathy (DR), and ... of OCU200 six weeks apart. Patient follow-up will take place up to three months after ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

As we can see above, the study met all endpoints, showing non-inferiority to aflibercept - Eylea - and woke the market up to the possibility ... Non-Proliferative Diabetic Retinopathy ("NPDR ...

In a subgroup of 36 eyes of 18 patients with at least two examinations over time, total macular volume (TMV) and volumes of all nine Early Treatment of Diabetic Retinopathy Study ... function that ...

Among all participants, 142 (70.0%) had regular follow-up visits. Additionally, diabetic-related complications were observed in the participants, with seven (3.4%) having retinopathy, nine (4.4%) with ...

Patients aged >18 years with either type I or II diabetes mellitus (defined per American Diabetes Association or WHO guidelines) with glycosylated haemoglobin (HbA 1c) values of ≤12% at screening and ...

To make meal planning a little easier, create a chart and follow these simple steps ... and sugary drinks should be very limited in a diabetes-friendly diet. If you have a celebration coming up where ...

Objectives More than 80% of cardiovascular diseases (CVD) and diabetes mellitus (DM ... these studies were limited by short follow-up duration (30 days to 1 or 2 years), treatment effects assessed as ...

Three experts discuss the increased mortality risk for patients with diabetic retinopathy, available screening tools, and ...